Kevin Yunjon Wu, OD
Optometry · Sunnyvale
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 7
- 3 carriers
- Offices
- 3
Offices
3 locations · Sutter Bay Medical Foundation · Mendelson and Mark Optometric Corporation
Looking this up.
Plans that list them
7 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Wu’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
7 of 7 plans
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
California Medical Board record
Licence C34003 · Cancelled
Licence status: Cancelled · since 1972 · University of Nebraska College of Medicine.
License has been voluntarily canceled, or the license has been expired for at least five years and has not been renewed. No practice is permitted.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$24,784
Medicare paid this office $24,784 for 174 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Established patient complete exam of visual system | 83 | $9,236 | $111 |
| Short return visit (20+ min) | 62 | $6,396 | $84 |
| New patient visit (30+ min) | 21 | $2,095 | $100 |
| Established patient problem focused exam of visual system | 15 | $1,469 | $92 |
| Imaging of optic nerve | 28 | $921 | $33 |
See all 8 services
| Established patient complete exam of visual system | 83 | $9,236 | $111 |
| Short return visit (20+ min) | 62 | $6,396 | $84 |
| New patient visit (30+ min) | 21 | $2,095 | $100 |
| Established patient problem focused exam of visual system | 15 | $1,469 | $92 |
| Imaging of optic nerve | 28 | $921 | $33 |
| Exam of visual field with extended testing | 12 | $801 | $57 |
| Imaging of retina | 19 | $733 | $39 |
| Photography of the retina | 18 | $632 | $35 |
Who their Medicare patients are
174 Original Medicare patients in 2024. Average age 75 · Women 63% · Also on Medicaid 8% · Health risk score 0.83. At or below the middle of the specialty; the typical optometry clinician is at 0.97.
Conditions among them: High blood pressure 59% · Diabetes 29% · Coronary heart disease 18% · Chronic kidney disease 14% · Cancer 14% · Atrial fibrillation 12% · Depression 10%.
The office billed $74,831, Medicare allowed $34,890 and paid $24,784; for 309 services of 19 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 174 | 309 | 75 | 0.83 | $74,831 | $24,784 |
| 2023 | 124 | 261 | 76 | 0.74 | $42,327 | $18,044 |
| 2022 | 143 | 332 | 76 | 0.73 | $55,790 | $25,317 |
| 2021 | 114 | 257 | 76 | 0.72 | $41,904 | $19,691 |
| 2020 | 65 | 127 | 76 | 0.90 | $19,465 | $9,559 |
| 2019 | 71 | 122 | 76 | 1.07 | $24,828 | $8,374 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 6 services
| Established patient complete exam of visual system | 55 | $5,894 | $107 |
| Established patient problem focused exam of visual system | 53 | $5,880 | $75 |
| Exam of visual field with extended testing | 21 | $1,177 | $51 |
| Imaging of retina | 13 | $603 | $38 |
| Photography of the retina | 14 | $506 | $34 |
| Exam of the internal drainage system of eye | 14 | $301 | $20 |
2022: 8 services
| Established patient problem focused exam of visual system | 81 | $11,349 | $81 |
| Established patient complete exam of visual system | 61 | $6,549 | $107 |
| New patient complete exam of visual system | 17 | $1,809 | $106 |
| Exam of visual field with extended testing | 20 | $1,476 | $62 |
| Imaging of retina | 16 | $569 | $32 |
| Photography of the retina | 16 | $483 | $28 |
| Imaging of optic nerve | 15 | $434 | $27 |
| Exam of the internal drainage system of eye | 14 | $390 | $28 |
2021: 5 services
| Established patient problem focused exam of visual system | 57 | $8,396 | $80 |
| Established patient complete exam of visual system | 55 | $5,877 | $107 |
| Exam of visual field with extended testing | 13 | $1,011 | $59 |
| Photography of the retina | 16 | $489 | $27 |
| Imaging of optic nerve | 12 | $374 | $31 |
2020: 2 services
| Established patient problem focused exam of visual system | 42 | $4,730 | $76 |
| Established patient complete exam of visual system | 23 | $2,534 | $110 |
2019: 2 services
| Established patient problem focused exam of visual system | 35 | $4,524 | $85 |
| Established patient complete exam of visual system | 19 | $1,389 | $73 |
Drugs they prescribed that Part D paid
$20,773
Pharmacies billed $20,773 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 82) in 2024. At or below the middle of the specialty; the typical optometry clinician is at 0%.
32 generic and 50 brand-name prescriptions · $20,773 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Xiidra | 11 | $10,266 | $933 |
| Latanoprost | 20 | $204 | $10 |
Year by year
| 2024 | 82 | 33 | 0% (0) | 61% | $20,773 |
| 2023 | 57 | 23 | 0% (0) | 54% | $14,926 |
| 2022 | 47 | 25 | 0% (0) | 60% | $17,845 |
| 2021 | 55 | 19 | 0% (0) | 80% | $26,781 |
| 2020 | 28 | 15 | 0% (0) | 64% | $9,983 |
| 2019 | 29 | 13 | 0% (0) | 76% | $14,951 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Latanoprost | 16 | $406 | $25 |
2022: 1 drug
| Restasis | 16 | $12,402 | $775 |
2021: 2 drugs
| Restasis | 13 | $12,292 | $946 |
| Cequa | 17 | $9,776 | $575 |
2019: 1 drug
| Restasis | 14 | $11,927 | $852 |
Money from drug and device companies
$838 in 2025
| 2025 | 8 | 38 | None | $838 |
| 2024 | 8 | 51 | None | $1,322 |
| 2023 | 6 | 24 | None | $765 |
| 2022 | 9 | 24 | None | $934 |
| 2021 | 5 | 31 | None | $489 |
| 2020 | 7 | 12 | None | $221 |
| 2019 | 4 | 11 | None | $1,637 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Tarsus Pharmaceuticals | Xdemvy | $480 | 29 payments
|
| Alcon Vision | Hydrus Microstent | $203 | 3 payments
|
| Abbvie | Lumigan | $33 | 1 payment
|
| Amgen | Tepezza | $32 | 1 payment
|
| Oyster Point Pharma | Tyrvaya | $26 | 1 payment
|
| Biotissue Holdings | None | $23 | 1 payment
|
See all 38 published payments
| Tarsus Pharmaceuticals | Meals · 2025-12-22 | Xdemvy | $6 |
| Tarsus Pharmaceuticals | Meals · 2025-12-09 | Xdemvy | $10 |
| Tarsus Pharmaceuticals | Meals · 2025-12-04 | Xdemvy | $5 |
| Tarsus Pharmaceuticals | Meals · 2025-12-02 | None | $14 |
| Tarsus Pharmaceuticals | Meals · 2025-12-01 | Xdemvy | $7 |
| Tarsus Pharmaceuticals | Meals · 2025-11-25 | Xdemvy | $8 |
| Tarsus Pharmaceuticals | Meals · 2025-11-17 | Xdemvy | $8 |
| Thea Pharma | Meals · 2025-11-13 | Iyuzeh | $20 |
| Tarsus Pharmaceuticals | Meals · 2025-11-13 | Xdemvy | $5 |
| Tarsus Pharmaceuticals | Meals · 2025-10-28 | Xdemvy | $5 |
| Alcon Vision | Meals · 2025-10-21 | Tryptyr | $24 |
| Oyster Point Pharma | Meals · 2025-10-14 | Tyrvaya | $26 |
| Tarsus Pharmaceuticals | Meals · 2025-10-06 | Xdemvy | $121 |
| Tarsus Pharmaceuticals | Meals · 2025-10-06 | Xdemvy | $8 |
| Tarsus Pharmaceuticals | Meals · 2025-09-29 | Xdemvy | $9 |
| Tarsus Pharmaceuticals | Meals · 2025-09-24 | Xdemvy | $6 |
| Tarsus Pharmaceuticals | Meals · 2025-09-15 | Xdemvy | $9 |
| Tarsus Pharmaceuticals | Meals · 2025-09-11 | Xdemvy | $5 |
| Abbvie | Meals · 2025-08-26 | Lumigan | $33 |
| Amgen | Meals · 2025-08-25 | Tepezza | $32 |
| Tarsus Pharmaceuticals | Meals · 2025-08-20 | Xdemvy | $6 |
| Tarsus Pharmaceuticals | Meals · 2025-07-23 | Xdemvy | $6 |
| Tarsus Pharmaceuticals | Meals · 2025-06-25 | Xdemvy | $6 |
| Alcon Vision | Meals · 2025-06-17 | Hydrus Microstent | $159 |
| Tarsus Pharmaceuticals | Meals · 2025-06-09 | Xdemvy | $33 |
| Tarsus Pharmaceuticals | Meals · 2025-05-29 | Xdemvy | $6 |
| Biotissue Holdings | Meals · 2025-05-26 | None | $23 |
| Tarsus Pharmaceuticals | Meals · 2025-05-20 | None | $146 |
| Tarsus Pharmaceuticals | Meals · 2025-04-23 | Xdemvy | $6 |
| Bausch & Lomb Americas | Meals · 2025-04-23 | Miebo | $22 |
| Tarsus Pharmaceuticals | Meals · 2025-04-09 | Xdemvy | $7 |
| Tarsus Pharmaceuticals | Meals · 2025-04-02 | Xdemvy | $6 |
| Tarsus Pharmaceuticals | Meals · 2025-03-26 | Xdemvy | $6 |
| Tarsus Pharmaceuticals | Meals · 2025-03-12 | Xdemvy | $6 |
| Tarsus Pharmaceuticals | Meals · 2025-03-12 | Xdemvy | $10 |
| Alcon Vision | Meals · 2025-01-29 | Eysuvis | $20 |
| Tarsus Pharmaceuticals | Meals · 2025-01-29 | Xdemvy | $6 |
| Tarsus Pharmaceuticals | Meals · 2025-01-08 | Xdemvy | $6 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $1,322
| Visionary Optics | None | $400 | 1 payment
|
| Biotissue Holdings | None | $351 | 10 payments
|
| Tarsus Pharmaceuticals | Xdemvy | $335 | 27 payments
|
| Bausch & Lomb Americas | Miebo | $146 | 8 payments
|
| Johnson & Johnson Vision Care | None | $28 | 1 payment
|
| Sun Pharmaceutical Industries | Cequa | $27 | 2 payments
|
| Alcon Vision | Dailies Total1 | $22 | 1 payment
|
| Oyster Point Pharma | Tyrvaya | $14 | 1 payment
|
2023: $765
| Oyster Point Pharma | Tyrvaya | $326 | 9 payments
|
| Sun Pharmaceutical Industries | Cequa | $202 | 8 payments
|
| Horizon Therapeutics plc | Tepezza | $178 | 4 payments
|
| Dompe US | Oxervate | $21 | 1 payment
|
| Novartis Pharmaceuticals | Xiidra | $19 | 1 payment
|
| Bausch & Lomb Americas | Vyzulta | $19 | 1 payment
|
2022: $934
| Johnson & Johnson Vision Care | Acuvue | $245 | 4 payments
|
| Oyster Point Pharma | Tyrvaya | $213 | 4 payments
|
| Sun Pharmaceutical Industries | Cequa | $205 | 7 payments
|
| Allergan | Vuity | $166 | 3 payments
|
| CooperVision | Multiple Brands Contact Lens | $42 | 2 payments
|
| Abbvie | Vuity | $21 | 1 payment
|
| Kala Pharmaceuticals | Inveltys | $15 | 1 payment
|
| Bausch & Lomb Americas | Alden Scleral Zenlens | $15 | 1 payment
|
| Novartis Pharmaceuticals | Xiidra | $12 | 1 payment
|
2021: $489
| Kala Pharmaceuticals | Inveltys | $238 | 19 payments
|
| Sun Pharmaceutical Industries | Cequa | $96 | 5 payments
|
| Johnson & Johnson Vision Care | Acuvue | $66 | 2 payments
|
| Novartis Pharmaceuticals | Xiidra | $65 | 4 payments
|
| Visioneering Technologies | None | $24 | 1 payment
|
2020: $221
| Novartis Pharmaceuticals | Xiidra | $59 | 3 payments
|
| TissueTech | Prokera | $42 | 3 payments
|
| Johnson & Johnson Vision Care | Acuvue | $27 | 2 payments
|
| Allergan | Restasis | $26 | 1 payment
|
| CooperVision | Onefit Contact Lens | $26 | 1 payment
|
| Kala Pharmaceuticals | Inveltys | $24 | 1 payment
|
| Carl Zeiss Meditec | None Specified | $17 | 1 payment
|
2019: $1,637
| Alcon Vision | Dailies | $1,230 | 5 payments
|
| Shire North American Group | Xiidra | $186 | 4 payments
|
| Bausch & Lomb a division of Bausch Health US | Biotrue | $125 | 1 payment
|
| Visioneering Technologies | None | $96 | 1 payment
|
Professional record
- NPI
- 1396221172
- Licence
- CA 34003California C34003: Cancelled
- Trained
- University of California - School of Optometry, 2018
- Group
- Sutter Bay Medical Foundation · Mendelson and Mark Optometric Corporation
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 152W00000X (152W00000X)
- Mailing address
- 1842 Lavender Crk, San Jose, CA, 95120
- NPI first listed
- 2018-07-16
- NPI last updated
- 2020-04-01
- NPI record certified
- 2020-04-01
This is when the NPI record was last certified, not a medical board exam.